Assessment of Quality of Life of Patients with Chronic Migraine on OnabotulinumtoxinA Therapy-A Study Performed at a Super Specialty Tertiary Hospital in Northeast India

20260 citationsJournal Articlehybrid Open Access

Authors

Nabajyoti Barkataky · Defence Research Laboratory

Amir Ali · National Institute of Pharmaceutical Education and Research

Ratan J. Lihite · National Institute of Pharmaceutical Education and Research

Rupjyoti Das · Defence Research Laboratory

Amit R. Barua · Gauhati Medical College and Hospital

Alfarid Shahid Ali · National Institute of Pharmaceutical Education and Research

Abstract

Our findings suggest that BoNT-A therapy can improve HRQol by reducing the incidence of migraine headaches. Thus, BoNT-A can be effective in the management of CM.

Topics & Keywords

Migraine and Headache Studies Spatial Neglect and Hemispheric Dysfunction Botulinum Toxin and Related Neurological Disorders

Publication Details

Published in: Neurology India

Volume 74, Issue 2, pp. 256-260

DOI: 10.4103/neurol-india.neurol-india-d-25-00249

Field-Weighted Citation Impact: 0.00

Command Palette

Assessment of Quality of Life of Patients with Chronic Migraine on OnabotulinumtoxinA Therapy-A Study Performed at a Super Specialty Tertiary Hospital in Northeast India

Authors

Abstract

Topics & Keywords

Publication Details